ETV6 and hematopoietic and lymphoid cell neoplasm: Definitive evidence of the prognostic influence of the <i>ETV6-ABL1</i> fusion in haematological neoplasms is lacking; however, overall data suggest that it is a poor prognostic factor, particularly in patients with ALL and AML.